Search

Becton Dickinson and Co

Aperta

SettoreSettore sanitario

198.6 0.5

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

196.93

Massimo

198.45

Metriche Chiave

By Trading Economics

Entrata

759M

449M

Vendite

269M

5B

P/E

Media del settore

46.209

50.373

EPS

3.23

Rendimento da dividendi

2.11

Margine di Profitto

9.011

Dipendenti

72,000

EBITDA

540M

1.2B

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

-3.07% downside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

2.11%

2.12%

Utili prossimi

5 nov 2026

Prossima data del Dividendo

30 dic 2026

Prossima data del' Ex Dividendo

7 dic 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

7.9B

53B

Apertura precedente

198.1

Chiusura precedente

198.6

Becton Dickinson and Co Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

31 ott 2026, 00:01 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reaching its highest level of the day and well above its 20-day moving average.

30 ott 2026, 21:51 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, continuing a strong performance that began shortly after the market closed.

29 ott 2026, 23:01 UTC

Becton Dickinson and Co shares are lower in after-market hours, reflecting broader market declines despite stronger-than-expected Q3 GDP growth.

28 ott 2026, 20:13 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

27 ott 2026, 19:16 UTC

Becton Dickinson and Co shares are declining, marking three consecutive lower daily closes, despite earlier rebounding from a session low.

26 ott 2026, 20:13 UTC

Becton Dickinson and Co's shares traded modestly lower during after-market hours on Monday, following a period of relative stability since the market closed.

24 ott 2026, 00:02 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

23 ott 2026, 23:21 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

22 ott 2026, 23:01 UTC

Becton Dickinson and Co shares fell in after-market trading, now at their lowest point of the day, moving lower since Thursday's close.

21 ott 2026, 19:56 UTC

Becton Dickinson and Co is experiencing a modest increase, currently positioned above its 20-day moving average and near the upper end of its one-month range.

20 ott 2026, 23:21 UTC

Correlated Moves

Becton Dickinson shares declined in after-market hours, influenced by disappointing earnings from holdings like Intuitive Surgical and Abbott Laboratories, amid broader sector weakness.

19 ott 2026, 22:21 UTC

Becton Dickinson and Co's shares rose in after-market trading, closing near session highs and reflecting a cumulative gain since Monday's close.

17 ott 2026, 00:01 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading following a drop shortly after Friday's close.

16 ott 2026, 23:11 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading, continuing a gradual decline from Friday's close while remaining above the 20-day moving average.

15 ott 2026, 20:02 UTC

Becton Dickinson and Co's shares are advancing amid significant gains in the Health Care Equipment sub-sector, remaining well above their 20-day moving average.

14 ott 2026, 23:51 UTC

Becton Dickinson shares are lower in after-market trading, reflecting a broader market decline amid renewed losses in semiconductor stocks and rising inflation concerns.

13 ott 2026, 19:46 UTC

Becton Dickinson and Co shares fell modestly after an early peak, reflecting typical performance for this time of day, while remaining above the 20-day moving average.

12 ott 2026, 22:01 UTC

Becton Dickinson and Co. shares declined modestly during after-market hours, continuing earlier losses amid unusual volatility and fluctuations in trading activity.

8 ott 2026, 20:01 UTC

News

Becton Dickinson advocates for reducing maternal mortality rates at the UN General Assembly, emphasizing advanced monitoring technologies for childbirth complications.

7 ott 2026, 19:50 UTC

News

Becton Dickinson shares fell sharply after Barclays initiated coverage with an Underweight rating and set a price target of $165, overshadowing positive trial results.

6 ott 2026, 21:51 UTC

News

Becton Dickinson and Co shares declined in after-market trading after Barclays initiated coverage with an Underweight rating and a $165.00 price target.

5 ott 2026, 20:31 UTC

Becton Dickinson and Co is experiencing a deeper decline in after-market trading, now modestly lower since Monday's close and near the lower end of its one-month range.

2 ott 2026, 19:26 UTC

Becton Dickinson and Co shares fell, continuing a trend of weaker closes over the past four sessions, remaining significantly below their 20-day moving average.

1 ott 2026, 20:07 UTC

Becton Dickinson and Co's shares fell, marking a fourth consecutive day of declines, closing below Wednesday's level and its 20-day moving average.

30 set 2026, 20:20 UTC

Becton Dickinson and Co is trading modestly lower in after-market hours, continuing a decline below its recent trend and significantly under its 20-day moving average.

29 set 2026, 20:07 UTC

Becton Dickinson and Co's shares are declining, reflecting a broader market trend, despite an earlier rebound from a session low.

28 set 2026, 19:15 UTC

Becton Dickinson and Co shares fell slightly, trading around the midpoint of their one-month range after fluctuating earlier in the session.

25 set 2026, 22:55 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reflecting upward movement from Friday's close, amid flat U.S. durable goods orders for August.

24 set 2026, 19:06 UTC

Becton Dickinson and Co shares fell sharply, reversing from an earlier peak and currently near the low end of their one-month range.

22 set 2026, 20:07 UTC

Becton Dickinson and Co is advancing, having gained ground since Monday's close, despite pulling back slightly from an earlier session peak.

Confronto tra pari

Modifica del prezzo

Becton Dickinson and Co Previsione

Obiettivo di Prezzo

By TipRanks

-3.07% in calo

Previsioni per 12 mesi

Media 191.8 USD  -3.07%

Alto 210 USD

Basso 165 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Becton Dickinson and Co - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

4

Acquista

5

Mantieni

1

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
help-icon Live chat